Medical technology company C.R. Bard Inc. announced Wednesday that its Board of Directors had approved the repurchase of up to $500 million in common stock.
This amount increases the approximately $30 million remaining from a previous repurchase authorization in January.
C.R. Bard has its headquarters in Murray Hill.
ALSO ON NJBIZ: